Results for
"[search-keyword]"
Sponsor content
30 result(s) found, displaying 21 to 30
-
Prescription medicine registrationActive ingredients: ravulizumab.
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial.
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STRENSIQ asfotase alfa rch 18 mg/0.45 ml solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STRENSIQ asfotase alfa rch 28 mg/0.70 ml solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STRENSIQ asfotase alfa rch 80 mg/0.80 ml injection solution vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STRENSIQ asfotase alfa rch 40 mg/1.00 ml solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STRENSIQ asfotase alfa rch 12 mg/0.30 ml solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SOLIRIS eculizumab (rmc) 300 mg/30 mL concentrated solution for intravenous infusion vial.